← Leaderboards
Matthew Thomas Henke
Harvard Medical School
$185,750
Attributed
$185,750
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $67.4K · FY2017–20$100K$75K$50K$25K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$185,750 · 1
By mechanism
F32$185,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Ulrich H Von Andrian$44,950,919
- Bernardo L Sabatini$25,331,480
- Hao Wu$47,906,316
- Steven P Gygi$23,279,525
- Arlene H Sharpe$68,359,602
Others in their field
Other Emerging Leaders on “Genes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,908,773
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$41,311,588
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Evan Z Macosko · Broad Institute, Inc.$32,734,698
Research focus
GenesGenomeGene DeletionGene ExpressionFractionationAffectAnalogGastrointestinal Tract StructureClinically RelevantComplexAutoimmune DiseasesData SetDendritic CellsBacteriaBone MarrowDisease ModelEnvironmentCellsEquilibriumEtiologyExhibitsExperimental DesignsCytokineGenomics
Grant awards (3)
Elucidating the role of an immunomodulator from a gut microbe in inflammatory bowel disease$67,446
F32 · FY2020 · GM · contact PI
Elucidating the role of an immunomodulator from a gut microbe in inflammatory bowel disease$61,610
F32 · FY2019 · GM · contact PI
Elucidating the role of an immunomodulator from a gut microbe in inflammatory bowel disease$56,694
F32 · FY2017 · GM · contact PI